US Bancorp’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

US Bancorp’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,757	Closed	-$71K	–	3725
2016 Q2	$71K	Buy	4,757 +539	+13%	+$6.92K	﹤0.01%	2241
2016 Q1	$51K	Buy	4,218 +72	+2%	+$1.01K	﹤0.01%	2378
2015 Q4	$66K	Buy	4,146 +2,608	+170%	+$41.1K	﹤0.01%	2302
2015 Q3	$24K	Buy	+1,538	New	+$33.2K	﹤0.01%	2802

US Bancorp's SGNT Position: Q3 2016 in Review

US Bancorp sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 4,757 shares — an estimated $71K sold.

US Bancorp first reported a position in SGNT in Q3 2015 and held it in 4 quarters. The position peaked at $71K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

US Bancorp reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
US Bancorp sold 4,757 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $71K.
US Bancorp first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 4 quarters.
US Bancorp's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $71K in Q2 2016.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.